Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation, commonly referred to as Novartis, is a leading global healthcare company headquartered in the United States. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established a strong presence in key operational regions, including Europe, Asia, and Latin America. Specialising in innovative pharmaceuticals, Novartis focuses on areas such as oncology, cardiology, immunology, and neuroscience. The company is renowned for its unique portfolio of patented medications and cutting-edge therapies, which have significantly advanced patient care. With a commitment to research and development, Novartis has achieved notable milestones, including the introduction of groundbreaking treatments that address unmet medical needs. As a prominent player in the pharmaceutical industry, Novartis continues to enhance its market position through strategic partnerships and a robust pipeline of new products.
DitchCarbon Score
How does Novartis Pharmaceuticals Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharmaceuticals Corporation's score of 65 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharmaceuticals Corporation's reported carbon emissions
Novartis Pharmaceuticals Corporation, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is challenging to assess their current emissions status or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies like Novartis are expected to engage in initiatives aimed at minimising their environmental impact, aligning with global climate goals. As the industry evolves, it is likely that Novartis will adopt more transparent reporting and ambitious targets in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novartis Pharmaceuticals Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
